Real-time Estimate
Other stock markets
|
|
5-day change | 1st Jan Change | |
69.56 USD | +0.79% | +5.82% | +13.25% |
Dec. 05 | HealthEquity's Fiscal Q3 Non-GAAP Earnings, Revenue Rise | MT |
Dec. 05 | Transcript : HealthEquity, Inc., Q3 2024 Earnings Call, Dec 05, 2023 | CI |
Business Summary
Number of employees : 3,189
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Service
49.9
%
| 427 | 56.4 % | 430 | 49.9 % | +0.77% |
Custodial
32.9
%
| 203 | 26.8 % | 283 | 32.9 % | +39.59% |
Interchange
17.2
%
| 127 | 16.8 % | 148 | 17.2 % | +17.04% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 757 | 100.0 % | 862 | 100.0 % | +13.90% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Neeleman
FOU | Founder | 55 | 2002 |
Jon Kessler
CEO | Chief Executive Officer | 55 | 2009 |
Elimelech Rosner
CTO | Chief Tech/Sci/R&D Officer | 66 | 2022 |
Angelique Hill
COO | Chief Operating Officer | 55 | 2018 |
Jody Dietel
CMP | Compliance Officer | - | 2018 |
Richard E Putnam
IRC | Investor Relations Contact | - | 2016 |
Tia Padia
SAM | Sales & Marketing | - | - |
Delano Ladd
LAW | General Counsel | 42 | 2016 |
Brad Bennion
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Black
BRD | Director/Board Member | 65 | 2022 |
Robert Selander
CHM | Chairman | 72 | 2015 |
Adrian Dillon
BRD | Director/Board Member | 69 | 2016 |
Jon Kessler
CEO | Chief Executive Officer | 55 | 2009 |
Frank Corvino
BRD | Director/Board Member | 74 | 2014 |
Evelyn Dilsaver
BRD | Director/Board Member | 67 | 2014 |
Stephen Neeleman
FOU | Founder | 55 | 2002 |
Stuart Parker
BRD | Director/Board Member | 51 | 2020 |
Debra McCowan
BRD | Director/Board Member | 51 | 2018 |
Gayle Wellborn
BRD | Director/Board Member | 62 | 2017 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 85,627,521 | 83,895,324 ( 97.98 %) | 0 | 97.98 % |
Company contact information
HealthEquity, Inc.
32 Loockerman Street Suite 201
19904, Dover
+801 727 1000
http://www.healthequity.com
Sales per Business
Trading Rating :
Investor Rating :
ESG Refinitiv :
B+
Sell
Buy

Mean consensus
BUY
Number of Analysts
12
Last Close Price
69.02USD
Average target price
85.83USD
Spread / Average Target
+24.36%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.97% | 5 910 M $ | |
+55.33% | 2769 B $ | |
+67.78% | 81 473 M $ | |
+63.21% | 71 329 M $ | |
+30.26% | 61 758 M $ | |
+48.09% | 49 212 M $ | |
+185.05% | 39 821 M $ | |
+52.42% | 33 502 M $ | |
+50.54% | 26 660 M $ | |
+42.90% | 25 367 M $ |
- Stock
- Equities
- Stock HealthEquity, Inc. - Nasdaq
- Company HealthEquity, Inc.